journal cover

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Jan 9, 2020

Adam M StaffaroniARTFL/LEFFTDS Consortium

PMID: 31914230

Abstract

Identifying clinical measures that track disease in the earliest stages of frontotemporal lobar degeneration (FTLD) is important for clinical trials. Familial FTLD provides a unique paradigm to study early FTLD. Executive dysfunction is a clinically relevant hallmark of FTLD and may be ...read more

Mentioned in this Paper

Human Study
Research
Frontotemporal Dementia
Frontotemporal Lobar Degeneration
Neuropsychological Tests
Clinical Trials
Deteriorating Vision
Genetic Carriers
Magnetic Resonance Imaging
Detected (Finding)
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Magnetic Resonance Imaging: Brain

Magnetic Resonance Imaging (MRI) is a non-invasive imaging technique that uses a powerful magnetic field and radio waves to generate images of the area of interest. MRI of the brain is commonly performed to visualize the brain and related structures in detail. Discover the latest research of MRI and the brain here.

Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Frontotemporal Lobar Degeneration

Frontotemporal lobar degeneration or frontotemporal dementia refers to a group of uncommon disorders that occur as a result of progressive nerve cell loss in the frontal and temporal lobes of the brain. Here is the latest research.

Dementia & Neurodegenerative Diseases

This feed focuses on the impact of insulin resistance, caloric restriction, cytokine singling, and metabolism on dementia and neurodegenerative diseases. Here is the latest research in this domain.

Corticobasal Degeneration

Corticobasal Degeneration (CBD)is a rare, neurodegenerative disease of the cerebral cortex and the basal ganglia, characterized by movement disorders. Discover the latest research on CBD here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

Frontotemporal Dementia

Frontotemporal dementia (FTD) refers to disorders caused by progressive neuronal loss in the frontal and temporal lobes of the brain. Here is the latest research on FTD and FTD-associated disorders.

Lysosome & C9orf72

This feed focuses on the C9orf72 protein and its possible role in lysosome function and implication in frontotemporal dementia and amyotrophic lateral sclerosis

Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.

Cognitive Decline: Environmental And Genetic Factors

This feed focuses on the role of environmental and genetic factors including environmental policies, disease susceptibility, and socioeconomic status on cognitive decline. Here is the latest research.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Progressive Supranuclear Palsy

Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder that affects movement, gait, balance, and speech. Discover the latest research on PSP here.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on the underlying role of Tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's.

Alzheimer's Disease: Early Markers

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on early markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Related Papers

Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationMay 16, 2019
Adam M StaffaroniARTFL/LEFFTDS Consortium
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationDecember 1, 2019
Nicholas T OlneyARTFL and LEFFTDS consortia
© 2020 Meta ULC. All rights reserved

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Jan 9, 2020

Adam M StaffaroniARTFL/LEFFTDS Consortium

PMID: 31914230

DOI:

Abstract

Identifying clinical measures that track disease in the earliest stages of frontotemporal lobar degeneration (FTLD) is important for clinical trials. Familial FTLD provides a unique paradigm to study early FTLD. Executive dysfunction is a clinically relevant hallmark of FTLD and may be ...read more

Mentioned in this Paper

Human Study
Research
Frontotemporal Dementia
Frontotemporal Lobar Degeneration
Neuropsychological Tests
Clinical Trials
Deteriorating Vision
Genetic Carriers
Magnetic Resonance Imaging
Detected (Finding)

Similar Papers Found In These Feeds

Magnetic Resonance Imaging: Brain

Magnetic Resonance Imaging (MRI) is a non-invasive imaging technique that uses a powerful magnetic field and radio waves to generate images of the area of interest. MRI of the brain is commonly performed to visualize the brain and related structures in detail. Discover the latest research of MRI and the brain here.

Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Related Papers

Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationMay 16, 2019
Adam M StaffaroniARTFL/LEFFTDS Consortium
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationDecember 1, 2019
Nicholas T OlneyARTFL and LEFFTDS consortia
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/assessment-of-executive-function-declines-in/31914230